Vanda Pharmaceuticals (VNDA) Treasury Shares (2009 - 2026)

Vanda Pharmaceuticals' Treasury Shares history runs 18 years deep, the most recent figure standing at $4.2 million for Q1 2026.

• In Q1 2026, Treasury Shares rose 26.67% year-over-year to $4.2 million; the TTM figure through Mar 2026 stood at $4.2 million (up 26.67% YoY), while the FY2025 annual figure was $3.5 million, up 31.19% from the prior year.
• Treasury Shares came in at $4.2 million for Q1 2026 at Vanda Pharmaceuticals, up from $3.5 million in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $4.2 million in Q1 2026 to a low of $1.9 million in Q4 2023.
• A 5-year average of $2.6 million and a median of $2.7 million in 2024 frame the typical range for Treasury Shares.
• Across the five-year window, Treasury Shares slipped 2.33% in 2023 and soared 42.05% in 2024, its largest moves.
• Vanda Pharmaceuticals' Treasury Shares stood at $1.9 million in 2022, then declined by 0.53% to $1.9 million in 2023, then surged by 39.09% to $2.7 million in 2024, then soared by 31.19% to $3.5 million in 2025, then gained by 21.49% to $4.2 million in 2026.
• According to Business Quant data, Treasury Shares over the past three periods registered $4.2 million, $3.5 million, and $3.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison